Summary of direct, indirect, and net evidence for the associations of tocilizumab, sarilumab and usual care or placebo with all-cause mortality 28 days after randomisation for patients receiving corticosteroids and either NIV, IMV or ECMO at randomisation.
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
Summary of direct, indirect, and net evidence for the associations of tocilizumab, sarilumab and usual care or placebo with all-cause mortality 28 days after randomisation for patients receiving corticosteroids and either NIV, IMV or ECMO at randomisation.
创建时间：
2022-07-08
相关数据集
暂无相关数据集
